Medical Device Marketing in Boston
Boston medtech companies sell into dense networks of teaching hospitals and investors, and every claim has to hold up. Our medtech work in Boston and Cambridge covers sites that engineers and clinicians find credible, content reviewed against your regulatory status, campaigns aimed at clinicians, value analysis committees, distributors, and investors, and a CRM that follows hospital deals for as long as they take.
Boston's medtech setting
The country's biggest cluster
CBRE ranks the Boston-Cambridge area as the country's biggest life sciences cluster by employment, lab inventory, NIH awards, and venture capital, as cited in the City of Boston's FY27 budget, and Cambridge's 2024 district assessment puts Kendall Square's biotechnology count above 120 companies. Device makers here compete for attention with deep-pocketed neighbors.
Headquarters on Summer Street
Haemonetics, a global medical technology company whose hospital business includes vascular closure and sensor-guided technologies, lists its corporate headquarters at 125 Summer Street in its fiscal 2025 annual report. The Commonwealth created the Massachusetts Life Sciences Center in 2006, and a 2008 law committed $1 billion over ten years to the industry. Funded startups and established firms chase the same clinicians.
FDA rules on promotion
FDA lists promotion or advertising of a device outside its cleared or approved indications as an example of regulatory misconduct to report. For restricted devices, advertisements must include a brief statement of intended uses and relevant warnings, precautions, side effects, and contraindications. Every page, ad, and sales sheet has to match your labeling.
Medtech marketing in practice
Claims tied to clearance
Copy starts from your cleared indications and the labeling FDA accepted, passes through regulatory and quality review, and every approved asset is logged with its sign-off.
Committees, not individuals
A purchase at a Boston teaching hospital typically involves physicians, nurses, supply chain staff, and a value analysis committee. Each needs evidence suited to its questions, from outcomes to total cost.
Investors read the site too
Startups raising money need a website that speaks to investors and partners as well as clinicians, with pipeline, team, and regulatory milestones presented accurately.
Help for Boston medtech
Areas we serve
Medtech campaigns can reach hospitals, labs, and device companies across these Boston neighborhoods and nearby cities:
- Cambridge
- Somerville
- Brookline
- Newton
- Quincy
- Waltham
- Back Bay
- Seaport
- South End
- Lexington
Questions and answers
Yes. We write from your cleared indications and labeling, send drafts through your regulatory reviewers, and log approvals. FDA treats promotion outside cleared or approved indications as reportable misconduct, so off-label language stays out of ads, pages, and sales materials.
Through the roles involved: clinical champions, supply chain leaders, value analysis committee members, and finance. Each gets targeted LinkedIn and search placements with evidence or cost material suited to its questions, and the CRM shows which health systems are warming up.
Not usually. Early companies need a credible site, investor-ready messaging, and first conversations with clinicians well before a full sales team exists. We scale the work to your stage and regulatory status.
Sources
- City of Boston FY27 budget, Volume 1: Boston's People and Economy (April 2026)
- City of Cambridge: Kendall Square district assessment (2024)
- Haemonetics Corporation annual report and Form 10-K for fiscal 2025 (SEC)
- Mass.gov: Overview of the Massachusetts Life Sciences Center
- FDA: Reporting allegations of regulatory misconduct (medical devices)
- FDA: General controls for medical devices
Checked 2026-10-31.